Source link : https://newshealth.biz/health-news/can-new-biomarker-help-identify-high-risk-dlbcl-patients/
For patients with diffuse large B-cell lymphoma (DLBCL), the detection of circulating tumor DNA (ctDNA) following first-line treatment is independently predictive of disease recurrence and overall survival over 2 years, suggesting important prognostic value of the biomarker to improve upon standard assessment with PET-CT imaging. “We demonstrated the prognostic value of ctDNA MRD [minimal residual […]
The post Can New Biomarker Help Identify High-Risk DLBCL Patients? first appeared on News Health.
—-
Author : News Health
Publish date : 2025-06-01 17:51:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8